SK8072003A3 - Use of pyrazolo[4,3-d]pyrimidines - Google Patents
Use of pyrazolo[4,3-d]pyrimidines Download PDFInfo
- Publication number
- SK8072003A3 SK8072003A3 SK807-2003A SK8072003A SK8072003A3 SK 8072003 A3 SK8072003 A3 SK 8072003A3 SK 8072003 A SK8072003 A SK 8072003A SK 8072003 A3 SK8072003 A3 SK 8072003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pyrazolo
- methyl
- phenyl
- alkyl
- pyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10060388A DE10060388A1 (de) | 2000-12-05 | 2000-12-05 | Verwendung von Pyrazolo [4,3-d]pyrimidinen |
PCT/EP2001/013036 WO2002045716A1 (de) | 2000-12-05 | 2001-11-09 | Verwendung von pyrazolo[4,3-d]pyrimidinen |
Publications (1)
Publication Number | Publication Date |
---|---|
SK8072003A3 true SK8072003A3 (en) | 2003-10-07 |
Family
ID=7665844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK807-2003A SK8072003A3 (en) | 2000-12-05 | 2001-11-09 | Use of pyrazolo[4,3-d]pyrimidines |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040023991A1 (es) |
EP (1) | EP1339410A1 (es) |
JP (1) | JP2004523493A (es) |
KR (1) | KR20030055338A (es) |
CN (1) | CN1479619A (es) |
AU (1) | AU2002216033A1 (es) |
BR (1) | BR0115911A (es) |
CA (1) | CA2436916A1 (es) |
CZ (1) | CZ20031752A3 (es) |
DE (1) | DE10060388A1 (es) |
HU (1) | HUP0302645A3 (es) |
MX (1) | MXPA03004907A (es) |
PL (1) | PL361890A1 (es) |
RU (1) | RU2003119546A (es) |
SK (1) | SK8072003A3 (es) |
WO (1) | WO2002045716A1 (es) |
ZA (1) | ZA200305181B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19942474A1 (de) * | 1999-09-06 | 2001-03-15 | Merck Patent Gmbh | Pyrazolo[4,3-d]pyrimidine |
DK1348707T3 (da) * | 2002-03-28 | 2010-12-13 | Ustav Ex Botan Av Cr V V I Inst Of Ex Botany Academy Of Sciences Of The Czech Republic Pro | Pyrazolo[4,3-d]pyrimidiner, fremgangsmåder til deres fremstilling samt deres terapeutiske anvendelse |
KR100468352B1 (ko) * | 2002-09-24 | 2005-01-27 | 한국과학기술연구원 | 신규 피라졸로피리미딘계 유도체, 그의 제조방법 및 이를 유효성분으로 하는 약학적 조성물 |
DK1475094T3 (da) * | 2003-05-06 | 2010-11-22 | Univ Palackeho | Pyrazolo[4,3-d]pyrimidiner, fremgangsmåde til deres fremstilling samt deres anvendelse |
BRPI0906475A2 (pt) * | 2008-01-11 | 2015-07-14 | Natco Pharma Ltd | Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto |
WO2020016850A1 (en) * | 2018-07-20 | 2020-01-23 | Merck Patent Gmbh | A substituted amino-pyrimidine compound for use in a method for treatment and prevention of multiple sclerosis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1530747A (en) * | 1976-04-05 | 1978-11-01 | Massachusetts Inst Technology | Pharmaceutical composition |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
CA2238283C (en) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
-
2000
- 2000-12-05 DE DE10060388A patent/DE10060388A1/de not_active Withdrawn
-
2001
- 2001-11-09 PL PL01361890A patent/PL361890A1/xx unknown
- 2001-11-09 WO PCT/EP2001/013036 patent/WO2002045716A1/de not_active Application Discontinuation
- 2001-11-09 JP JP2002547500A patent/JP2004523493A/ja active Pending
- 2001-11-09 AU AU2002216033A patent/AU2002216033A1/en not_active Abandoned
- 2001-11-09 BR BR0115911-9A patent/BR0115911A/pt not_active Application Discontinuation
- 2001-11-09 KR KR10-2003-7007498A patent/KR20030055338A/ko not_active Application Discontinuation
- 2001-11-09 CZ CZ20031752A patent/CZ20031752A3/cs unknown
- 2001-11-09 CN CNA018200737A patent/CN1479619A/zh active Pending
- 2001-11-09 SK SK807-2003A patent/SK8072003A3/sk unknown
- 2001-11-09 CA CA002436916A patent/CA2436916A1/en not_active Abandoned
- 2001-11-09 HU HU0302645A patent/HUP0302645A3/hu unknown
- 2001-11-09 MX MXPA03004907A patent/MXPA03004907A/es unknown
- 2001-11-09 RU RU2003119546/15A patent/RU2003119546A/ru not_active Application Discontinuation
- 2001-11-09 EP EP01999373A patent/EP1339410A1/de not_active Withdrawn
- 2001-11-09 US US10/433,678 patent/US20040023991A1/en not_active Abandoned
-
2003
- 2003-07-03 ZA ZA200305181A patent/ZA200305181B/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0115911A (pt) | 2004-02-25 |
MXPA03004907A (es) | 2003-09-05 |
US20040023991A1 (en) | 2004-02-05 |
JP2004523493A (ja) | 2004-08-05 |
WO2002045716A1 (de) | 2002-06-13 |
CN1479619A (zh) | 2004-03-03 |
KR20030055338A (ko) | 2003-07-02 |
CA2436916A1 (en) | 2002-06-13 |
EP1339410A1 (de) | 2003-09-03 |
AU2002216033A1 (en) | 2002-06-18 |
RU2003119546A (ru) | 2004-12-27 |
DE10060388A1 (de) | 2002-06-06 |
HUP0302645A2 (hu) | 2003-11-28 |
ZA200305181B (en) | 2004-10-04 |
PL361890A1 (en) | 2004-10-04 |
CZ20031752A3 (cs) | 2003-10-15 |
HUP0302645A3 (en) | 2005-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6495554B2 (en) | Thienopyrimidines | |
SK7352003A3 (en) | Use of thienopyrimidines | |
SK3132002A3 (en) | Thienopyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions comprising them | |
SK15972000A3 (sk) | Derivát kondenzovaného tienopyrimidínu s pde v inhibičným pôsobením, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje | |
SK18222001A3 (sk) | Derivát tienopyrimidínu ako inhibítor fosfodiesterázy, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje | |
SK10782003A3 (sk) | Farmaceutický prostriedok obsahujúci parazolo [4,3-d]pyrimidíny a endotelínové receptorové antagonisty alebo tienopyrimidíny a endotelínové receptorové antagonisty | |
SK7592003A3 (en) | Use of pyrazolo[4,3-D]pyrimidines | |
US20040077664A1 (en) | Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates | |
SK8072003A3 (en) | Use of pyrazolo[4,3-d]pyrimidines | |
JP4927299B2 (ja) | チエノピリミジン | |
SK3322002A3 (en) | Use of thienopyrimidines | |
MXPA00005232A (es) | Tienopirimidinas |